Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 15, 2019Journal of Clinical MedicineOpen Access

Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus

View Full Paper
Ask AI
Bookmark
Share

Authors

HTHiroyuki TakahashiNSNaoaki SakataGYGumpei Yoshimatsu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Takahashi et al. (2019) studied this question.

synapsesocial.com/papers/6a89348e851416c68bf7bcfbhttps://doi.org/10.3390/jcm8020249
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mesenchymal stromal cells improve human islet function through released products and extracellular matrix2017 · 67 citations
  2. 2Islet Regeneration During the Reversal of Autoimmune Diabetes in NOD Mice2003 · 358 citations
  3. 3Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes2016 · 60 citations
  4. 4Effect of bone marrow stromal cell transplantation on neurologic function and expression of VEGF in rats with focal cerebral ischemia2014 · 23 citations
  5. 5Diabetes impairs the angiogenic potential of adipose-derived stem cells by selectively depleting cellular subpopulations2014 · 182 citations